PUBLICATIONS · 33026938
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2020 Dec 10
- First author
- Kojima T
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2021 Jul 10;39(20):2317-2318. doi: 10.1200/JCO.20.03262.
- note
- Source null
- related pmid
- 33844589
- relationship
- Comment in
Authors and identifiers
- name
- Kojima T
- type
- Author
- name
- Shah MA
- type
- Author
- name
- Muro K
- type
- Author
- name
- Francois E
- type
- Author
- name
- Adenis A
- type
- Author
- name
- Hsu CH
- type
- Author
- name
- Doi T
- type
- Author
- name
- Moriwaki T
- type
- Author
- name
- Kim SB
- type
- Author
- name
- Lee SH
- type
- Author
- name
- Bennouna J
- type
- Author
- name
- Kato K
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Kojima T
- type
- Author
- name
- Shah MA
- type
- Author
- name
- Muro K
- type
- Author
- name
- Francois E
- type
- Author
- name
- Adenis A
- type
- Author
- name
- Hsu CH
- type
- Author
- name
- Doi T
- type
- Author
- name
- Moriwaki T
- type
- Author
- name
- Kim SB
- type
- Author
- name
- Lee SH
- type
- Author
- name
- Bennouna J
- type
- Author
- name
- Kato K
- type
- Author
- bibliography ids
- nci-bib-7df37aefd7c8ab2f6627d993
- book metadata
- content sha256
- 2c07e45782f73b3744910ff40687769537595502379a0f467172d7b5ba1aa692
- document type
- citation
- dois
- 10.1200/JCO.20.01888
- electronic publication date
- display
- 2020 Oct 7
- precision
- day
- year
- 2020
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:33026938
- immutable id
- pubmed:33026938@2c07e45782f73b3744910ff40687769537595502379a0f467172d7b5ba1aa692
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 35
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 4138-4148
- volume
- 38
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2021 Jul 10;39(20):2317-2318. doi: 10.1200/JCO.20.03262.
- note
- Source null
- related pmid
- 33844589
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 33026938
- provenance
- batch id
- 9bca82d1bba2b27adc79
- provider
- NCBI PubMed ESummary
- record sha256
- 8dfc5521bcd4fe362a89895e47082edffdd49132c02ac1b0ee06610417007742
- response sha256
- c8a4853c65a45038af15f5ade3970763bfa121cf5c68bafcc52c3a06860d0211
- retrieved at
- 2026-09-09T23:47:56.131551+00:00
- publication date
- display
- 2020 Dec 10
- precision
- day
- year
- 2020
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer.
Preserved source evidence · Not medical advice
Triangle